Veracyte, Inc. <VCYT.O>: UBS raises target price to $65 from $52
VCYT•Related News
India lifts ban on JPMorgan unit, broker in market-manipulation case, sources say
JPM•
LifeStance Health falls after $275 mln secondary offering prices
LFST•
Oxbridge Re executive team attends H.C. Wainwright Global Investment Conference
OXBR•
Nasdaq trade halt continues <MGN.O> volatility trading pause at 09:38 AM
MGN•
SLB N.V. <SLB.N>: UBS Raises Target Price To $72 From $66
SLB•